These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38841811)

  • 1. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma.
    Trejo-Solís C; Serrano-García N; Castillo-Rodríguez RA; Robledo-Cadena DX; Jimenez-Farfan D; Marín-Hernández Á; Silva-Adaya D; Rodríguez-Pérez CE; Gallardo-Pérez JC
    Rev Neurosci; 2024 Oct; 35(7):813-838. PubMed ID: 38841811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
    Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH3α regulates one-carbon metabolism in glioblastoma.
    May JL; Kouri FM; Hurley LA; Liu J; Tommasini-Ghelfi S; Ji Y; Gao P; Calvert AE; Lee A; Chandel NS; Davuluri RV; Horbinski CM; Locasale JW; Stegh AH
    Sci Adv; 2019 Jan; 5(1):eaat0456. PubMed ID: 30613765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
    Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
    Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate and α-ketoglutarate: key players in glioma metabolism.
    Maus A; Peters GJ
    Amino Acids; 2017 Jan; 49(1):21-32. PubMed ID: 27752843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.
    Cortes Ballen AI; Amosu M; Ravinder S; Chan J; Derin E; Slika H; Tyler B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Reprogramming in Glioma.
    Strickland M; Stoll EA
    Front Cell Dev Biol; 2017; 5():43. PubMed ID: 28491867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.
    Nguyen TTT; Shang E; Westhoff MA; Karpel-Massler G; Siegelin MD
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting metabolic remodeling in glioblastoma multiforme.
    Wolf A; Agnihotri S; Guha A
    Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation of metabolism in glioblastoma.
    Dong Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity.
    Scagliola A; Mainini F; Cardaci S
    Antioxid Redox Signal; 2020 Apr; 32(12):834-852. PubMed ID: 31847530
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
    Mala U; Baral TK; Somasundaram K
    BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment.
    Lee H; Kim D; Youn B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle.
    Bowtell JL; Marwood S; Bruce M; Constantin-Teodosiu D; Greenhaff PL
    Sports Med; 2007; 37(12):1071-88. PubMed ID: 18027994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
    Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond glucose: alternative sources of energy in glioblastoma.
    Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK
    Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multifaceted Metabolism of Glioblastoma.
    Quinones A; Le A
    Adv Exp Med Biol; 2018; 1063():59-72. PubMed ID: 29946775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.